Biodesix (BDSX) EBT Margin (2019 - 2026)
Biodesix's (BDSX) quarterly EBT Margin came in at 33.26% in Q1 2026, up 2700.0% YoY from 1.19% in Q1 2025, and down 137.54% on a QoQ basis from 14.0% in Q4 2025.
Biodesix (BDSX) EBT Margin (2019 - 2026) Analysis & Trends
Biodesix (BDSX) has 8 years of EBT Margin data on file, last reported at 33.26% in Q1 2026.
- Quarterly EBT Margin rose 2700.0% year-over-year to 33.26% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 91.98% (down 3823.0% YoY) and the FY2025 annual result came in at 151.86%, up 3530.0% from the prior year.
- EBT Margin declined to 33.26% in Q1 2026, from 14.0% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 14.0% in Q4 2025 to a low of 713.75% in Q1 2023.
- A 5-year average of 173.17% and a median of 91.44% in 2024 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2023 — EBT Margin plunged 45402 bps — and 2024, when it soared 62230 bps.
- Tracing BDSX's EBT Margin over 5 years: stood at 97.61% in 2022, then climbed by 8 bps to 89.75% in 2023, then soared by 54 bps to 41.12% in 2024, then jumped by 66 bps to 14.0% in 2025, then plunged by 138 bps to 33.26% in 2026.
- The last three EBT Margin figures came in at 33.26% (Q1 2026), 14.0% (Q4 2025), and 108.89% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 16.04% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 17.21% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 34.29% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 22.23% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 6.89% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -12.17% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 22.43% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 28.17% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 13.54% |
| 10 | Biodesix | 220.74 Mn | 195.16 Mn | 21.35 Mn | -33.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.26% |
| Dec 31, 2025 | -14.00% |
| Sep 30, 2025 | -108.89% |
| Jun 30, 2025 | -260.57% |
| Mar 31, 2025 | -60.26% |
| Dec 31, 2024 | -41.12% |
| Sep 30, 2024 | -58.58% |
| Jun 30, 2024 | -56.75% |
| Mar 31, 2024 | -91.44% |
| Dec 31, 2023 | -89.75% |
| Sep 30, 2023 | -90.89% |
| Jun 30, 2023 | -285.27% |
| Mar 31, 2023 | -713.75% |
| Dec 31, 2022 | -97.61% |
| Sep 30, 2022 | -313.04% |
| Jun 30, 2022 | -369.02% |
| Mar 31, 2022 | -259.73% |
| Dec 31, 2021 | -143.18% |
| Sep 30, 2021 | -373.65% |
| Jun 30, 2021 | -264.14% |